Ulster University
Food4PD — a functional drink for gut health and nutrition in Parkinson's
An Ulster University trial testing a drink enriched with inulin fibre, B vitamins and vitamin D against a placebo drink over 12 weeks in people with Parkinson's, measuring fibre intake, gut microbiome, gastrointestinal symptoms, constipation, Parkinson's symptoms and quality of life. My Moves Matter contributed to the study design.
Why this research matters
Constipation affects most people with Parkinson's, and nutrition is one of the few levers available for non-motor symptoms like it. Dietary fibre such as inulin has shown promise for constipation in Parkinson's, and several B vitamins and vitamin D are also of interest. Food4PD asks whether a single enriched drink can deliver these nutrients practically and what effect that has.
Design
A 12-week feasibility trial at Ulster University's Human Intervention Studies Unit in Coleraine. Participants were randomly allocated, double-blind, to a functional drink enriched with chicory inulin, folic acid, vitamins B12, B6, riboflavin and vitamin D, or to a placebo drink of similar energy content, taken twice daily. Outcomes include dietary fibre intake, gut microbiome profile, gastrointestinal symptoms and constipation, Parkinson's symptoms and quality of life, with blood markers of B vitamins, vitamin D and inflammation as secondary measures.
My Moves Matter's role
My Moves Matter contributed to the design of the study. The research is led by Professor Helene McNulty at the Nutrition Innovation Centre for Food and Health, where Richelle Flanagan completed her master's in dietetics, and funded by the RIPEN Innovation Hub.
Status
Thirty-seven adults with Parkinson's were enrolled. The trial is registered as active and no longer recruiting, with primary data collection complete in April 2026 and completion estimated for December 2026. Results have not been reported.
What this study can show
As a feasibility trial with 37 participants, Food4PD can show whether the drink is acceptable and whether the planned measurements are workable, and it can give early signals on the outcomes. It is not designed to prove a treatment effect, and none is claimed here.
Facts on this page last reviewed 2026-10-24.
